企業プロフィール
BCR 株価・ニュース・カタリスト
- ティッカー:
- BCR
- 取引所:
- NYSE
- セクター:
- Biopharma
- 所在地:
- United States
株価変動の要因
Current closing-price context is not available for BCR.
企業概要
事業概要
C. R. Bard was a medical technology company with broad exposure to vascular, urology, and surgical products before being acquired by Becton Dickinson. It represented a durable device and procedure-driven healthcare franchise.
所在地とセクター分類
Bard was headquartered in the United States and traded on NYSE before the acquisition. Its business was rooted in medical devices rather than biotech or pharma.
ビジネスモデルの特徴
The company generated revenue through procedure-linked products, hospital adoption, and recurring device demand. Investors historically watched product cycles, hospital purchasing, and the stability of its surgical and vascular franchise.
バイオ業界での位置付け
Bard was outside biotech and closer to the medtech infrastructure layer. Since it was acquired, it is best treated as a historical healthcare infrastructure name.
今後のカタリスト
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。